Literature DB >> 15055346

Should serum IGF-I concentrations be monitored routinely during growth hormone therapy?

Maria Papagianni1, Richard Stanhope.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15055346     DOI: 10.1515/jpem.2004.17.2.141

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


× No keyword cloud information.
  1 in total

1.  Combined evaluation of IGF-1 and IGFBP-3 as an index of efficacy and safety in growth hormone treated patients.

Authors:  Zeynep Sıklar; Gönül Öcal; Merih Berberoğlu; Pelin Bilir
Journal:  J Clin Res Pediatr Endocrinol       Date:  2009-08-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.